Stephen L. Sabba, Director: Ligand Pharmaceuticals LGND Planned sale · Filed 25/03/18

Trade details

Type: Planned sale notice
Stock: Ligand Pharmaceuticals LGND
Person: Stephen L. SabbaDirector
Planned sale date: 25/03/18
Filed: 25/03/18

$255K to be sold

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/16~25/04/17

Stephen L. Sabba's recent trades

Stephen L. SabbaDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$544.8K
2,145 sh
$544.8K
Filed 06/18
Traded 06/16
Stephen L. SabbaDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$544.8K
2,145 sh
$544.8K
Filed 06/16
Traded 06/16
Stephen L. SabbaDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$207.9K
1,000 sh
$207.9K
Filed 03/25
Traded 03/23
Stephen L. SabbaDirector
Planned saleLigand Pharmaceuticals
Planned sale
Ligand Pharmaceuticals
LGND
$207.9K
1,000 sh
$207.9K
Filed 03/23
Traded 03/23
Stephen L. SabbaDirector
SellLigand Pharmaceuticals
Sell
Ligand Pharmaceuticals
LGND
$409.9K
2,034 sh
$409.9K
Filed 03/05
Traded 03/03